UNC Science Short: CRISPR/Cas9 to treat Angelman Syndrome
Mark Zylka, PhD, director of the UNC Neuroscience Center, is using CRISPR/Cas9 technology to determine if the gene editing … source
Mark Zylka, PhD, director of the UNC Neuroscience Center, is using CRISPR/Cas9 technology to determine if the gene editing …